View of Study of p16 biomarker after short-period primary endocrinotherapy with tamoxifen and anastrozole in postmenopausal women with breast carcinoma

Return to Article Details Study of p16 biomarker after short-period primary endocrinotherapy with tamoxifen and anastrozole in postmenopausal women with breast carcinoma Download Download PDF